Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of MLN8237 in Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00962091
First received: August 18, 2009
Last updated: July 1, 2013
Last verified: July 2013